--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--
US Stock MarketDetailed Quotes
CARA Cara Therapeutics
- 6.120
- +1.860+43.66%
Close Dec 31 16:00 ET
- 6.270
- +0.150+2.45%
Post 19:59 ET
27.98MMarket Cap-0.29P/E (TTM)
6.360High4.150Low334.08KVolume4.180Open4.260Pre Close1.78MTurnover8.57%Turnover RatioLossP/E (Static)4.57MShares13.80052wk High39.23P/B23.86MFloat Cap2.70852wk Low--Dividend TTM3.90MShs Float355.768Historical High--Div YieldTTM51.88%Amplitude2.700Historical Low5.328Avg Price1Lot Size
Cara Therapeutics Key Stats
Cara Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Cara Therapeutics Earnings Reports
Read more
Heat List
US
Overall
Symbol
Price
% Chg
No Data
